US Patent

US9750711 — Low dose oral pharmaceutical composition of isotretinoin

Formulation · Assigned to Sun Pharmaceutical Industries Ltd · Expires 2035-05-29 · 9y remaining

Vulnerability score 42/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects a low-dose oral pharmaceutical composition of isotretinoin with reduced or no food effect.

USPTO Abstract

The present invention provides a low dose oral pharmaceutical composition of isotretinoin having reduced food effect, in particular no food effect. The present invention further relates to a process for preparing the oral pharmaceutical composition of the present invention.

Drugs covered by this patent

Patent Metadata

Patent number
US9750711
Jurisdiction
US
Classification
Formulation
Expires
2035-05-29
Drug substance claim
No
Drug product claim
Yes
Assignee
Sun Pharmaceutical Industries Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.